Ally Bridge Group (“ABG”) is a global healthcare-focused investment group founded by Frank Yu. Mr. Yu and his team began their track record of successful healthcare investing in 2011 in China, and have since evolved to global healthcare investors. Today, ABG and its affiliates manage close to approximately US$2 billion in assets and a portfolio of some of the world’s most novel life science companies and technologies in the United States, Europe and China.